Everolimus in Breast Cancer Patients After Pre-operative Chemotherapy

NCT01088893 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Breast Neoplasms

Interventions

DRUG: Everolimus

Sponsor

Organisation for Oncology and Translational Research